当前位置: X-MOL 学术Open Heart › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe
Open Heart Pub Date : 2021-08-01 , DOI: 10.1136/openhrt-2021-001681
Michelle Claire Williams 1 , Leslee Shaw 2 , Cole B Hirschfeld 3 , Pal Maurovich-Horvat 4 , Bjarne L Nørgaard 5 , Gianluca Pontone 6 , Amelia Jimenez-Heffernan 7 , Valentin Sinitsyn 8 , Vladimir Sergienko 9 , Alexey Ansheles 9 , Jeroen J Bax 10 , Ronny Buechel 11 , Elisa Milan 12 , Riemer H J A Slart 13 , Edward Nicol 14 , Chiara Bucciarelli-Ducci 15, 16 , Yaroslav Pynda 17 , Nathan Better 18 , Rodrigo Cerci 19 , Sharmila Dorbala 20 , Paolo Raggi 21 , Todd C Villines 22 , Joao Vitola 19 , Eli Malkovskiy 3 , Benjamin Goebel 23 , Yosef Cohen 24 , Michael Randazzo 3 , Thomas N B Pascual 25 , Maurizio Dondi 17 , Diana Paez 17 , Andrew J Einstein 26 ,
Affiliation  

Objectives We aimed to explore the impact of the COVID-19 pandemic on cardiac diagnostic testing and practice and to assess its impact in different regions in Europe. Methods The online survey organised by the International Atomic Energy Agency Division of Human Health collected information on changes in cardiac imaging procedural volumes between March 2019 and March/April 2020. Data were collected from 909 centres in 108 countries. Results Centres in Northern and Southern Europe were more likely to cancel all outpatient activities compared with Western and Eastern Europe. There was a greater reduction in total procedure volumes in Europe compared with the rest of the world in March 2020 (45% vs 41%, p=0.003), with a more marked reduction in Southern Europe (58%), but by April 2020 this was similar in Europe and the rest of the world (69% vs 63%, p=0.261). Regional variations were apparent between imaging modalities, but the largest reductions were in Southern Europe for nearly all modalities. In March 2020, location in Southern Europe was the only independent predictor of the reduction in procedure volume. However, in April 2020, lower gross domestic product and higher COVID-19 deaths were the only independent predictors. Conclusion The first wave of the COVID-19 pandemic had a significant impact on care of patients with cardiac disease, with substantial regional variations in Europe. This has potential long-term implications for patients and plans are required to enable the diagnosis of non-COVID-19 conditions during the ongoing pandemic. No data are available. As data were provided in confidence to the IAEA by survey respondents, sharing of the underlying data is not possible.

中文翻译:

COVID-19对欧洲心脏病影像诊断的影响

目标 我们旨在探讨 COVID-19 大流行对心脏诊断测试和实践的影响,并评估其对欧洲不同地区的影响。方法 国际原子能机构人类健康司组织的在线调查收集了 2019 年 3 月至 2020 年 3 月/4 月期间心脏成像程序体积变化的信息。数据收集自 108 个国家的 909 个中心。结果 与西欧和东欧相比,北欧和南欧的中心更有可能取消所有门诊活动。2020 年 3 月,与世界其他地区相比,欧洲的手术总量减少幅度更大(45% vs 41%,p=0.003),其中南欧减少更为明显(58%),但到 2020 年 4 月欧洲和世界其他地区的情况类似(69% vs 63%,p=0.261)。成像方式之间存在明显的地区差异,但几乎所有方式的下降幅度最大的是南欧。2020 年 3 月,南欧地点是手术量减少的唯一独立预测因素。然而,2020 年 4 月,国内生产总值下降和 COVID-19 死亡人数增加是唯一的独立预测因素。结论 第一波 COVID-19 大流行对心脏病患者的护理产生了重大影响,但欧洲的地区差异很大。这对患者具有潜在的长期影响,并且需要制定计划以便能够在持续的大流行期间诊断非 COVID-19 病症。无可用数据。由于调查受访者向原子能机构秘密提供数据,因此不可能共享基础数据。
更新日期:2021-08-05
down
wechat
bug